Neurokon Pharmaceuticals Private Limited
About Neurokon Pharmaceuticals Private Limited
Data last updated:
Neurokon Pharmaceuticals Private Limited is a private limited company based in Qutub Vihar, Delhi, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 14 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24309DL2020PTC360251.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Sanjeev Kumar and Munni Prasad Singh.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at S – 233 D – Block Phase – 1 Goyal Dairy, Qutub Vihar, Delhi, India – 110071.
Company details
Contact details
Neurokon Pharmaceuticals Private Limited's registered office is in Qutub Vihar, Delhi.
- Registered AddressS – 233 D – Block Phase – 1 Goyal Dairy, Qutub Vihar, Delhi, India – 110071
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Neurokon Pharmaceuticals Private Limited
FY 2020 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2019-20 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Neurokon Pharmaceuticals Private Limited, buy the company report.
Board of directors of Neurokon Pharmaceuticals Private Limited
Neurokon Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjeev Kumar | Director | 14 Jan 2020 | 6 Years 9 Months | Current |
| Munni Prasad Singh | Director | 16 Jan 2020 | 6 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving Neurokon Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neurokon Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Neurokon Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Neurokon Pharmaceuticals Private Limited has 6 board changes on record since 2020: 2 appointments and 4 cessations. The latest: Munni Prasad Singh ceased to be Director on 09 Feb 2022.
Frequently asked questions
Neurokon Pharmaceuticals is an active private limited company based in Qutub Vihar, Delhi, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 14 January 2020 (6+ years old) and is registered under CIN U24309DL2020PTC360251.
Neurokon Pharmaceuticals has 2 current directors:
- Sanjeev Kumar - Director
- Munni Prasad Singh - Director
The latest financial statements of Neurokon Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Neurokon Pharmaceuticals is U24309DL2020PTC360251. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neurokon Pharmaceuticals was incorporated on 14 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Munni Prasad Singh ceased to be Director on 09 Feb 2022. Sanjeev Kumar ceased to be Director on 20 Dec 2021. Pinky Devi ceased to be Director on 02 Aug 2021. Neurokon Pharmaceuticals has 6 board changes on record in total.
The registered office of Neurokon Pharmaceuticals is at S – 233 D – Block Phase – 1 Goyal Dairy, Qutub Vihar, Delhi, India – 110071.
Neurokon Pharmaceuticals operates in the food and beverages industry, in the manufacturing segment.
Neurokon Pharmaceuticals can be reached at its registered office: S – 233 D – Block Phase – 1 Goyal Dairy, Qutub Vihar, Delhi, India – 110071.
Neurokon Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.